7*24 Hotline：
Hainan Kangzhi Pharmaceutical Co., Ltd. (300086)
Kangzhi Pharmaceutical Co., Ltd. (Stock Code: 300086) is a listed company focusing on children's health. The company's main business covers children's medicine, reproductive medicine, women's and children's health care, infant and child health care products and other fields. It is a national high-tech enterprise, and takes the lead in setting up an enterprise post doctoral research workstation with children's medicine as the main research direction.
Kangzhi pharmaceutical acquired Yunnan Jiuzhou hospital and Kunming and Wanjia hospital in 2018, and formally entered the child health industry with reproductive medicine technology as the core. Its reproductive medicine technology and medical services are in the leading position in Southwest China. In the same year, Kangzhi pharmaceutical acquired Zhongshan care daily necessities Co., Ltd. and extended the development of infant and child health care plate. The company has established cooperation with many universities and scientific research institutions at home and abroad, and was invited to participate in the development of infant and child washing liquid industry standards. It is a leading enterprise in the domestic infant and child health care industry.
In early 2020, novel coronavirus pneumonia epidemic swept the world. The emergency production of respirators and other protective materials in Kang Zhi pharmaceutical industry completed the first disposable medical mask production line in Hainan in 8 days. Kangzhi pharmaceutical actively builds the production base of medical protection, improves the industrial chain of epidemic prevention and disaster prevention, and has successfully obtained the EN ISO 13485:2016 EU quality management system certification, and has obtained the white list "double certification" published by the Ministry of Commerce and China Chamber of Commerce for import and export of health care products. In September 2020, after a multi-level investigation by the United Nations development program, Kangzhi pharmaceutical became a manufacturer of anti epidemic mask materials of the United Nations development program.
oil wellhead